» Articles » PMID: 19822747

Design and X-ray Crystal Structures of High-potency Nonsteroidal Glucocorticoid Agonists Exploiting a Novel Binding Site on the Receptor

Abstract

Crystallography and computer modeling have been used to exploit a previously unexplored channel in the glucocorticoid receptor (GR). Highly potent, nonsteroidal indazole amides showing excellent complementarity to the channel were designed with the assistance of the computational technique AlleGrow. The accuracy of the design process was demonstrated through crystallographic structural determination of the GR ligand-binding domain-agonist complex of the D-prolinamide derivative 11. The utility of the channel was further exemplified through the design of a potent phenylindazole in which structural motifs, seen to interact with the traditional GR ligand pocket, were abandoned and replaced by interactions within the new channel. Occupation of the channel was confirmed with a second GR crystal structure of this truncated D-alaninamide derivative 13. Compound 11 displays properties compatible with development as an intranasal solution formulation, whereas oral bioavailability has been demonstrated with a related truncated exemplar 14. Data with the pyrrolidinone amide 12 demonstrate the potential for further elaboration within the "meta" channel to deliver compounds with selectivity for the desired transrepressive activity of glucocorticoids. The discovery of these interactions with this important receptor offers significant opportunities for the design of novel GR modulators.

Citing Articles

HIt Discovery using docking ENriched by GEnerative Modeling (HIDDEN GEM): A novel computational workflow for accelerated virtual screening of ultra-large chemical libraries.

Popov K, Wellnitz J, Maxfield T, Tropsha A Mol Inform. 2023; 43(1):e202300207.

PMID: 37802967 PMC: 11156482. DOI: 10.1002/minf.202300207.


The Biologist's Guide to the Glucocorticoid Receptor's Structure.

Deploey N, Van Moortel L, Rogatsky I, Peelman F, De Bosscher K Cells. 2023; 12(12).

PMID: 37371105 PMC: 10297449. DOI: 10.3390/cells12121636.


The multivalency of the glucocorticoid receptor ligand-binding domain explains its manifold physiological activities.

Jimenez-Panizo A, Alegre-Marti A, Tettey T, Fettweis G, Abella M, Anton R Nucleic Acids Res. 2022; 50(22):13063-13082.

PMID: 36464162 PMC: 9825158. DOI: 10.1093/nar/gkac1119.


Dimerization of the Glucocorticoid Receptor and Its Importance in (Patho)physiology: A Primer.

Timmermans S, Vandewalle J, Libert C Cells. 2022; 11(4).

PMID: 35203332 PMC: 8870481. DOI: 10.3390/cells11040683.


GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life.

Louw A Front Immunol. 2019; 10:1693.

PMID: 31379877 PMC: 6653659. DOI: 10.3389/fimmu.2019.01693.


References
1.
Biggadike K, Bledsoe R, Hassell A, Kirk B, McLay I, Shewchuk L . X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain. J Med Chem. 2008; 51(12):3349-52. DOI: 10.1021/jm800279t. View

2.
Schacke H, Schottelius A, Docke W, Strehlke P, Jaroch S, Schmees N . Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci U S A. 2003; 101(1):227-32. PMC: 314167. DOI: 10.1073/pnas.0300372101. View

3.
Newton R, Holden N . Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?. Mol Pharmacol. 2007; 72(4):799-809. DOI: 10.1124/mol.107.038794. View

4.
Lipinski C, Lombardo F, Dominy B, Feeney P . Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001; 46(1-3):3-26. DOI: 10.1016/s0169-409x(00)00129-0. View

5.
Madauss K, Bledsoe R, Mclay I, Stewart E, Uings I, Weingarten G . The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist. Bioorg Med Chem Lett. 2008; 18(23):6097-9. DOI: 10.1016/j.bmcl.2008.10.021. View